FROS IN THE NEWS

FROS attending physician, Josephine Kang, M.D., Ph.D., will present two posters at this year's upcoming ASTRO meeting on use of RT for atypical lipomas and SBRT for metastatic melanoma.

June 1, 2012

Josephine Kang, M.D., Ph.D., who is joining FROS Radiation Oncology Cyberknife Center this August after having recently completed her residency at the Harvard Radiation Oncology Program, has been selected for two poster presentations at the 2012 International ASTRO Conference.  Dr. Kang’s posters are: Management of Metastatic Melanoma with Stereotactic Body Radiotherapy and Management of Atypical Lipomas with Radiation.

FROS IN THE NEWS

A new study from Duke University shows that women with early stages of breast cancer who undergo a lumpectomy coupled with radiation treatment have a higher survival rate than those who have mastectomies.

January 29, 2013

Durham, N.C. — A new study from Duke University shows that women with early stages of breast cancer who undergo a lumpectomy coupled with radiation treatment have a higher survival rate than those who have mastectomies.

Previous research showed the two operations produced the same results. This is the first study to say lumpectomies with radiation may be a better option.

"Women who are on the fence about it, women as they make their own decision, this will support them in the idea that this is a very good treatment option for them," said Freya Schnabel, director of breast surgery at New York University's Langone Medical Center.

After Toni Spring, 50, was diagnosed with breast cancer last summer, she decided to have a lumpectomy – a smaller operation than a mastectomy, which removes the entire breast.

"(I am) very happy with the choice," she said. "I didn't have to stay in the hospital for longer than the surgery and a couple hours after recover."

Over the last decade, many breast cancer patients, especially younger women, have opted to have their entire breasts removed. Schnabel said this study could reverse that trend.

"I think sometimes patients think that because mastectomy is a bigger operation, that it means it's a better treatment," she said.

Experts say factors such as tumor size and family history should be considered when choosing a treatment. Spring went to three doctors – two advised she have one or more breasts removed.

Spring said she was relieved to find out a lumpectomy could be just as effective.

"It was very empowering that I had this choice that I didn't really think I had," she said.

If her cancer comes back, she can have a mastectomy if she needs one.

Click here for source

August 28, 2013

FROS Radiation Oncology celebrated the opening of their third radiation oncology facility in the Lower East Side of Manhattan. Physicians, employees, family and friends celebrated the opening of Manhattan Radiation Oncology located at 47 Essex Street in lower Manhattan on August 28, 2013. FROS Radiation Oncology is excited to partner with Elekta in bringing the most advanced cancer treatment technology to the residents of lower Manhattan. The Elekta Synergy Linear Accelerator provides patients with the most advanced technology to track cancer and spare normal tissue.

At FROS we give our patients the option of being treated by two of the most technologically advanced cancer treatments with the Cyberknife Radiosurgery System and the Elekta Synergy Linear Accelerator.

Contribute!

LOCATIONS

Flushing: 40-22 Main St, 4th Fl,
Flushing, NY 11354
Brooklyn: 1737 Bath Ave
Brooklyn, NY 11214
Manhattan: 47 Essex St.
New York, NY 10002

STAY CONNECTED

Stay in touch with FROS Radiation Oncology & Cyberknife Centers. Join us on Facebook, Twitter and LinkedIn for latest news and info.